Total Funding
$162M
Employee Range
51-100
Mineralys Therapeutics is developing innovative treatments for hypertension. They are a clinical-stage biopharmaceutical company dedicated to improving patient outcomes.
Mineralys Therapeutics data powered by:
Share
Mineralys Therapeutics data powered by:
Mineralys TherapeuticsOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
Mineralys TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
1st
In Radnor
Top 20%out of 5 startups
National Rank
Share
932nd
In United States
Top 11%out of 8871 startups
Regional Rank
Share
969th
In North America
Top 11%out of 9667 startups
Mineralys TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Radnor
Top 25%out of 4 startups
National Rank
Share
321st
In United States
Top 10%out of 3471 startups
Regional Rank
Share
332nd
In North America
Top 9%out of 3719 startups
rankings by:
Mineralys TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
Mineralys TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro